Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04175730 · ClinicalTrials.gov registry record · NA

Prostate Cancer Detection Screening MRI Protocol

A NA study, sponsored by University of Illinois at Chicago.

Completed
Registry status
NA
Development phase
48
Enrollment target

NCT04175730: Completed NA study, sponsored by University of Illinois at Chicago.

NCT04175730 is a NA study that has completed, run by University of Illinois at Chicago. The registered enrollment target is 48 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04175730, a NA study, has completed, sponsored by University of Illinois at Chicago.

COMPLETED
Registry status
NA
Development phase
48 participants
Enrollment target

Study Summary

Whether a quantitative detection specfic magnetic resonance imaging (MRI) protocol improves prostate cancer (PCa) detection in biopsy naïve men is not adequately studied.

Primary Outcome

Per subject prevalence of any grade or high grade (Gleason score 7 or higher) prostate cancer as measured by histopathology. When looking at cells under the microscope, the doctor assigns a grade between 1-5. 1 means almost normal and 5 means very different from normal. Adding to two most common grades determines the Gleason score. Higher numbers indicate a faster growing cancer

Interventions

  • DEVICE Ultrasound
  • DEVICE Ultrasound and MRI

Trial Details

FieldValue
Enrollment Target 48 participants
Start Date 2019-05-20
Est. Completion 2020-12-14
Phase NA
University of Illinois at Chicago

430 total trials

What the finished NCT04175730 record still lists

NCT04175730 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 48 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).

The record links to 0 conditions, and to 2 interventions - of which Ultrasound is the first listed.

NCT04175730 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT04175730 about?

NCT04175730 is a clinical study titled "Prostate Cancer Detection Screening MRI Protocol". Whether a quantitative detection specfic magnetic resonance imaging (MRI) protocol improves prostate cancer (PCa) detection in biopsy naïve men is not adequately studied.

What is the current status of trial NCT04175730?

This trial is currently completed. It is a NA study. The enrollment target is 48 participants. The study started on 2019-05-20. Estimated completion is 2020-12-14.

What interventions are being tested in trial NCT04175730?

The interventions under investigation include: Ultrasound (DEVICE), Ultrasound and MRI (DEVICE).

Who is sponsoring clinical trial NCT04175730?

This trial is sponsored by University of Illinois at Chicago, which has 430 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT04175730's enrollment target sits among peer trials

48 1381st of 2000 higher than 601 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01765777 · 48 participants · NA

    Efficacy of Osteopathic Manipulative Medicine (OMM) and Phototherapy for Patients With Chronic Lower Back Pain

  • NCT03073343 · 48 participants · NA

    A Prospective, Randomized, Open Label Trial of Two Doses of Oral Betaine

  • NCT03431064 · 48 participants

    Lung Recruitment Maneuver as a Potential Predictor of Fluid Responsiveness in Mechanically Ventilated Pediatric Patients

  • NCT03514602 · 48 participants · NA

    Maternal Smoking Cessation and Pediatric Obesity Prevention

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04175730, the US trial registry maintained by the National Library of Medicine. NCT04175730 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.